Cargando…
Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication
Ivermectin (IVM) is an FDA approved macrocyclic lactone compound traditionally used to treat parasitic infestations and has shown to have antiviral potential from previous in-vitro studies. Currently, IVM is commercially available as a veterinary drug but have also been applied in humans to treat on...
Autores principales: | Low, Zheng Yao, Yip, Ashley Jia Wen, Lal, Sunil K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526435/ https://www.ncbi.nlm.nih.gov/pubmed/34687900 http://dx.doi.org/10.1016/j.bbadis.2021.166294 |
Ejemplares similares
-
SARS coronavirus outbreaks past and present—a comparative analysis of SARS-CoV-2 and its predecessors
por: Low, Zheng Yao, et al.
Publicado: (2021) -
The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review
por: Zaidi, Asiya Kamber, et al.
Publicado: (2021) -
Prospective mode of action of Ivermectin: SARS-CoV-2
por: Patil, Vaishali M., et al.
Publicado: (2022) -
SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
por: Low, Zheng Yao, et al.
Publicado: (2022) -
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
por: Caly, Leon, et al.
Publicado: (2020)